Latest Insider Transactions at Agios Pharmaceuticals, Inc. (AGIO)
This section provides a real-time view of insider transactions for Agios Pharmaceuticals, Inc. (AGIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AGIOS PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AGIOS PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.67%
|
$180,000
$9.05 P/Share
|
|
Feb 16
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
233
-8.03%
|
$6,291
$27.21 P/Share
|
|
Feb 16
2023
|
Jacqualyn A Fouse Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,648
-4.23%
|
$102,144
$28.91 P/Share
|
|
Feb 16
2023
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
609
-2.52%
|
$17,052
$28.91 P/Share
|
|
Feb 14
2023
|
Jacqualyn A Fouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,333
+11.62%
|
-
|
|
Feb 14
2023
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,738
+6.71%
|
-
|
|
Feb 14
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
504
-14.8%
|
$14,112
$28.59 P/Share
|
|
Feb 14
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-5.76%
|
$11,200
$28.68 P/Share
|
|
Feb 14
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
360
+9.25%
|
-
|
|
Feb 14
2023
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
758
-4.27%
|
$21,224
$28.44 P/Share
|
|
Feb 14
2023
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
643
-2.79%
|
$18,004
$28.44 P/Share
|
|
Feb 13
2023
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
20,000
-14.51%
|
$560,000
$28.62 P/Share
|
|
Feb 13
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.67%
|
$180,000
$9.05 P/Share
|
|
Feb 10
2023
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,162
+10.85%
|
-
|
|
Feb 10
2023
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,834
+7.37%
|
-
|
|
Feb 10
2023
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
777
+18.4%
|
-
|
|
Jan 30
2023
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
20,000
-7.42%
|
$580,000
$29.55 P/Share
|
|
Jan 30
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.67%
|
$180,000
$9.05 P/Share
|
|
Jan 17
2023
|
David P Schenkein Director |
SELL
Open market or private sale
|
Direct |
20,000
-7.31%
|
$580,000
$29.16 P/Share
|
|
Jan 17
2023
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+12.67%
|
$180,000
$9.05 P/Share
|
|
Jan 13
2023
|
Kaye I Foster Cheek Director |
SELL
Bona fide gift
|
Direct |
2,200
-25.15%
|
-
|
|
Dec 28
2022
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,783
-15.13%
|
$77,924
$28.48 P/Share
|
|
Dec 28
2022
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,597
-10.9%
|
$72,716
$28.48 P/Share
|
|
Dec 23
2022
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+33.77%
|
-
|
|
Dec 23
2022
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+26.87%
|
-
|
|
Dec 06
2022
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
248
-2.68%
|
$6,944
$28.83 P/Share
|
|
Dec 02
2022
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
833
+8.25%
|
-
|
|
Oct 17
2022
|
Richa Poddar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,485
-14.86%
|
$40,095
$27.48 P/Share
|
|
Oct 15
2022
|
Richa Poddar Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+33.35%
|
-
|
|
May 20
2022
|
Kaye I Foster Cheek Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+15.34%
|
-
|
|
May 20
2022
|
John Maraganore Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+5.01%
|
-
|
|
May 20
2022
|
Maykin Ho Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+19.49%
|
-
|
|
May 20
2022
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+1.33%
|
-
|
|
May 20
2022
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+19.49%
|
-
|
|
May 20
2022
|
David Scadden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+18.21%
|
-
|
|
May 20
2022
|
Paul J Clancy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,585
+19.49%
|
-
|
|
Feb 25
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
108
-4.06%
|
$3,240
$30.0 P/Share
|
|
Feb 22
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
59
-2.17%
|
$1,711
$29.08 P/Share
|
|
Feb 22
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
167
+5.79%
|
-
|
|
Feb 22
2022
|
David P Schenkein Director |
SELL
Payment of exercise price or tax liability
|
Direct |
758
-0.65%
|
$21,982
$29.08 P/Share
|
|
Feb 22
2022
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,775
+2.32%
|
-
|
|
Feb 22
2022
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
215
-1.43%
|
$6,235
$29.08 P/Share
|
|
Feb 22
2022
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
724
+4.6%
|
-
|
|
Feb 22
2022
|
Jacqualyn A Fouse Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,674
-4.68%
|
$106,546
$29.08 P/Share
|
|
Feb 22
2022
|
Jonathan Biller Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,688
-10.48%
|
$77,952
$29.08 P/Share
|
|
Feb 22
2022
|
Bruce Car Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,041
-10.86%
|
$59,189
$29.08 P/Share
|
|
Feb 22
2022
|
Richa Poddar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
742
-14.32%
|
$21,518
$29.08 P/Share
|
|
Feb 22
2022
|
Richa Poddar Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
658
+11.27%
|
-
|
|
Feb 22
2022
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
955
-10.95%
|
$27,695
$29.08 P/Share
|
|
Feb 18
2022
|
Jacqualyn A Fouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,379
+13.61%
|
-
|